ReachMD
Be part of the knowledge.™
Popular
What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
MinuteCE®What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
1.00 program creditsAgainst the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
Medical Industry FeatureAgainst the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
The Dynamic Practice: Exploring Locum Tenens Opportunities
Spotlight on Locum TenensThe Dynamic Practice: Exploring Locum Tenens Opportunities
The Network Effect: Analyzing Brain Structures to Treat Depression
Medical Industry FeatureThe Network Effect: Analyzing Brain Structures to Treat Depression
Stopping aspirin after 1 month DAPT in ACS patients after stenting
ACC Action CenterStopping aspirin after 1 month DAPT in ACS patients after stenting
Mechanism of Disease: Immunoglobulin A Nephropathy
Medical Industry FeatureMechanism of Disease: Immunoglobulin A Nephropathy
Programs
The Dynamic Practice: Exploring Locum Tenens Opportunities
Spotlight on Locum TenensThe Dynamic Practice: Exploring Locum Tenens Opportunities
Stopping aspirin after 1 month DAPT in ACS patients after stenting
ACC Action CenterStopping aspirin after 1 month DAPT in ACS patients after stenting
Inflammatory Pathways in Severe Asthma: Focus on Mucus Plugs
Medical Industry FeatureInflammatory Pathways in Severe Asthma: Focus on Mucus Plugs
Addressing Treatment Gaps Among Patients with MDS-Associated Anemia
Medical Industry FeatureAddressing Treatment Gaps Among Patients with MDS-Associated Anemia
Pruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
CME/CEPruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
0.25 creditsNo improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
ACC Action CenterNo improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
Clinical Practice
What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
MinuteCE®What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
1.00 program creditsMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
ACC Action CenterMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Preventing Ischemic Stroke in Today’s World
MinuteCE®Preventing Ischemic Stroke in Today’s World
1.50 program creditsHead-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
ACC Action CenterHead-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
CMV Infection After Transplant: Who’s at Risk and How to Manage?
Medical Industry FeatureCMV Infection After Transplant: Who’s at Risk and How to Manage?
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Medical Industry FeatureConfronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Doctors Lounge
Let’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic
CME/CELet’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic
0.25 creditsDisparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
NeuroFrontiersDisparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
Poster Pearl: Detecting Cancer with an MCED Test and Treating It Surgically Improves Outcomes
Project Oncology®Poster Pearl: Detecting Cancer with an MCED Test and Treating It Surgically Improves Outcomes
Op-Ed: Workplace Burnout and Physician/Medical Student Well-Being
Op-EdOp-Ed: Workplace Burnout and Physician/Medical Student Well-Being
Preventing HIV & Substance Use in Incarcerated Women: Can an App Help?
Clinician's RoundtablePreventing HIV & Substance Use in Incarcerated Women: Can an App Help?
Patients with PPD & Anxiety in Urban Areas Are Less Likely to Receive Treatment
Advances in Women's HealthPatients with PPD & Anxiety in Urban Areas Are Less Likely to Receive Treatment
CME
- CME/CE Meeting
April 16, 2024
11:30 AM - 01:30 PM CST
Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice
Extending Treatment Durability With Next-Generation Neovascular AMD Therapies
CME/CEExtending Treatment Durability With Next-Generation Neovascular AMD Therapies
0.50 creditsImproving Outcomes in Patients with RVO: Tailoring Treatment
CME/CEImproving Outcomes in Patients with RVO: Tailoring Treatment
1.00 creditsNavigating the Evolving Landscape: Advanced Decision-Making in ATTR-CM
CME/CE Live BroadcastApril 29, 2024
09:00 PM - 10:30 PM ET
Navigating the Evolving Landscape: Advanced Decision-Making in ATTR-CM
South Asians With IBD: Underrepresented and Underappreciated
CME/CESouth Asians With IBD: Underrepresented and Underappreciated
0.25 creditsEfficacy Data for Bispecific Antibodies in RRMM
MinuteCE®Efficacy Data for Bispecific Antibodies in RRMM
1.00 program credits
Industry Feature
Advancements in Pretreated Metastatic Triple-Negative Breast Cancer
Medical Industry FeatureAdvancements in Pretreated Metastatic Triple-Negative Breast Cancer
Identifying Appropriate Patients for Acute Seizure Treatment
Medical Industry FeatureIdentifying Appropriate Patients for Acute Seizure Treatment
The Gene Messenger: Advancing Neurological Gene Therapy
Medical Industry FeatureThe Gene Messenger: Advancing Neurological Gene Therapy
Deep Learner: Building AI to Improve Cardiovascular Care
Medical Industry FeatureDeep Learner: Building AI to Improve Cardiovascular Care
An FDA-Approved Therapeutic Treatment Option for Polymyalgia Rheumatica
Broadcast ReplayAn FDA-Approved Therapeutic Treatment Option for Polymyalgia Rheumatica
The Pathophysiology of Anemia of CKD
Medical Industry FeatureThe Pathophysiology of Anemia of CKD
